A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale

Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study

(2017) Hashim U Ahmed et al.   LANCET

Trends in prostate cancer in elderly in Denmark, 1980–2012

(2016) Mads Hvid Poulsen et al.   ACTA ONCOLOGICA

Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years

(2016) Paul F. Pinsky et al.   CANCER

Estimating bias in causes of death ascertainment in the Finnish Randomized Study of Screening for Prostate Cancer

(2016) Tuomas P. Kilpeläinen et al.   Cancer Epidemiology

Multiparametric Magnetic Resonance Imaging in the Diagnosis of Prostate Cancer: A Systematic Review

(2016) M.A. Haider et al.   CLINICAL ONCOLOGY

A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort

(2016) Katharina Braun et al.   EUROPEAN UROLOGY

Screening for Colorectal Cancer

(2016) Jennifer S. Lin et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Baseline Prostate-Specific Antigen Levels in Midlife Predict Lethal Prostate Cancer

(2016) Mark A. Preston et al.   JOURNAL OF CLINICAL ONCOLOGY

Prostate cancer detection rates of magnetic resonance imaging-guided prostate biopsy related to Prostate Imaging Reporting and Data System score

(2016) Daniël F. Osses et al.   WORLD JOURNAL OF UROLOGY

A Multi-institutional Prospective Trial in the USA Confirms that the 4Kscore Accurately Identifies Men with High-grade Prostate Cancer

(2015) Dipen J. Parekh et al.   EUROPEAN UROLOGY

Comparison Between the Four-kallikrein Panel and Prostate Health Index for Predicting Prostate Cancer

(2015) Tobias Nordström et al.   EUROPEAN UROLOGY

Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective Study

(2015) Nicola Fossati et al.   EUROPEAN UROLOGY

Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature

(2015) Jurgen J. Fütterer et al.   EUROPEAN UROLOGY

Magnetic Resonance Imaging–targeted Biopsy May Enhance the Diagnostic Accuracy of Significant Prostate Cancer Detection Compared to Standard Transrectal Ultrasound-guided Biopsy: A Systematic Review and Meta-analysis

(2015) Ivo G. Schoots et al.   EUROPEAN UROLOGY

Economic evaluation of prostate cancer screening: a systematic review

(2015) Chunhuan Lao et al.   Future Oncology

Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study

(2015) Richard J. Bryant et al.   JNCI-Journal of the National Cancer Institute

Predicting High-Grade Cancer at Ten-Core Prostate Biopsy Using Four Kallikrein Markers Measured in Blood in the ProtecT Study

(2015) Richard J. Bryant et al.   JNCI-Journal of the National Cancer Institute

Detection of Prostate Cancer by an Electronic Nose: A Proof of Principle Study

(2014) Antti Roine et al.   JOURNAL OF UROLOGY

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

(2014) Fritz H Schröder et al.   LANCET

Influence of Study Features and Methods on Overdiagnosis Estimates in Breast and Prostate Cancer Screening

(2013) Ruth Etzioni et al.   ANNALS OF INTERNAL MEDICINE

Time from diagnosis to surgery and prostate cancer survival: a retrospective cohort study

(2013) Maria Theresa Redaniel et al.   BMC CANCER

Predictive Value of Four Kallikrein Markers for Pathologically Insignificant Compared With Aggressive Prostate Cancer in Radical Prostatectomy Specimens: Results From the European Randomized Study of Screening for Prostate Cancer Section Rotterdam

(2013) Sigrid Carlsson et al.   EUROPEAN UROLOGY

Optimization of Initial Prostate Biopsy in Clinical Practice: Sampling, Labeling and Specimen Processing

(2013) Marc A. Bjurlin et al.   JOURNAL OF UROLOGY

Guidelines on processing and reporting of prostate biopsies: the 2013 update of the pathology committee of the European Randomized Study of Screening for Prostate Cancer (ERSPC)

(2013) T. Van der Kwast et al.   VIRCHOWS ARCHIV

Strategy for detection of prostate cancer based on relation between prostate specific antigen at age 40-55 and long term risk of metastasis: case-control study

(2013) A. J. Vickers et al.   BMJ-British Medical Journal

Detection of smell print differences between nonmalignant and malignant prostate cells with an electronic nose

(2012) Antti Roine et al.   Future Oncology

Quality-of-Life Effects of Prostate-Specific Antigen Screening

(2012) Eveline A.M. Heijnsdijk et al.   NEW ENGLAND JOURNAL OF MEDICINE

Number of screens for overdetection as an indicator of absolute risk of overdiagnosis in prostate cancer screening

(2011) Grace Hui-Min Wu et al.   INTERNATIONAL JOURNAL OF CANCER

The number of women who would need to be screened regularly by mammography to prevent one death from breast cancer

(2011) Valerie Beral et al.   JOURNAL OF MEDICAL SCREENING

Overdetection, overtreatment and costs in prostate-specific antigen screening for prostate cancer

(2009) E A M Heijnsdijk et al.   BRITISH JOURNAL OF CANCER

Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context

(2009) G. Draisma et al.   JNCI-Journal of the National Cancer Institute